相关实验视频

Updated: Mar 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

ALKBH5通过PD-L1调节促进急性髓性白血病的发展和免疫逃脱

Xin Ma¹, Cong Zhao¹, Ying Xi¹

¹Department of Clinical Laboratory, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China.

Frontiers in oncology

|March 16, 2026

概括

m6A脱甲基酶ALKBH5通过调节PD-L1并损害T细胞功能来促进急性髓性白血病 (AML) 的进展和免疫逃避. 准ALKBH5可能为AML患者提供新的免疫治疗策略.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

急性髓性白血病 (AML) 是一种复杂的血液性恶性瘤,其特征是免疫逃避.
编程死亡连接体1 (PD-L1) 对于瘤免疫逃生至关重要,但其在AML中的调节尚未完全理解.
m6A脱甲基酶ALKBH5在AML中过度表达,与疾病进展有关,但其在PD-L1轴和免疫微环境中的作用尚不清楚.

研究的目的:

研究ALKBH5在AML进展和免疫逃避中的作用.
分析ALKBH5在AML中的预后意义.
探索ALKBH5在AML中的PD-L1表达和T细胞功能上的调节机制.

主要方法:

对ALKBH5表达和预后价值的公共数据库 (BloodSpot,GEO,TCGA) 的生物信息分析.
在来自AML患者和健康对照的骨髓样本中进行RT-qPCR验证.
在体外研究使用ALKBH5敲击AML细胞系来评估扩散,迁移和PD-L1水平.
与AML细胞和PBMC进行共同培养实验,以评估T细胞抗瘤作用.

主要成果:

ALKBH5在AML中显著过度表达,与预后不佳和与免疫相关的信号通路相关.
在AML患者中ALKBH5水平升高与原始细胞和PD-L1表达的增加有关.
ALKBH5 knockdown 抑制了AML细胞的增殖和迁移,降低了PD-L1蛋白 (而不是mRNA),并增强了CD8+ T细胞活性和细胞因子分泌 (IFN-γ,TNF-α).

结论:

ALKBH5通过调节PD-L1和调节T细胞功能来促进AML的进展和免疫逃脱.
ALKBH5对PD-L1的后转录调节是AML免疫逃避的一个关键机制.
向ALKBH5为新型AML免疫疗法提供了潜在的战略.

关键词:

在 ALKBH5H5 中 N6 - 甲基氨酸 (m6A) 的使用.在PD-L1中.急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.瘤免疫微环境是一个微环境.

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...